SUVEN

Suven Life Sciences Share PriceSuven Life Sciences

₹59.4
As on 08 February, 2023 | 10:25 BSE: 530239 NSE: SUVEN

Suven Life Sciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Suven Life Sciences

Start SIP

Suven Life Sciences Share Price

  • Over 1 Month -7.9%
  • Over 3 Month -2.7%
  • Over 6 Month -17.03%
  • Over 1 Year -32.75%

Suven Life Sciences Key Statistics

P/E Ratio -11.6
PEG Ratio -1.3
Market Cap Cr 1,295
Price to Book Ratio 13.5
EPS -1.7
Dividend 0
Relative Strength Index 37.83
Money Flow Index 54.45
MACD Signal -0.83
Average True Range 2.28

Suven Life Sciences Investment Rating

  • Master Rating:
  • Suven Life Sciences has an operating revenue of Rs. 15.15 Cr. on a trailing 12-month basis. An annual revenue de-growth of -19% needs improvement, Pre-tax margin of -1030% needs improvement, ROE of -126% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 24 which is a POOR score indicating inconsistency in earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 103 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Suven Life Sciences Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 3444
Operating Expenses Qtr Cr 10121112
Operating Profit Qtr Cr -7-7-7-7
Depreciation Qtr Cr 2221
Interest Qtr Cr 0000
Tax Qtr Cr 0000
Net Profit Qtr Cr -7-9-2-9

Suven Life Sciences Technicals

EMA & SMA

Current Price
₹59.4
(0%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 62.3
  • 50 Day
  • 63.66
  • 100 Day
  • 65.69
  • 200 Day
  • 70.1
  • 20 Day
  • 62.72
  • 50 Day
  • 63.86
  • 100 Day
  • 65.36
  • 200 Day
  • 70.06

Suven Life Sciences Resistance and Support

PIVOT
₹59.82
Resistance
First Resistance 60.59
Second Resistance 61.77
Third Resistance 62.54
RSI 37.83
MFI 54.45
MACD Single Line -0.83
MACD -1.24
Support
First Resistance 58.64
Second Resistance 57.87
Third Resistance 56.69

Suven Life Sciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 231,771 15,459,126 66.7
Week 249,628 11,964,660 47.93
1 Month 229,946 10,359,063 45.05
6 Month 396,091 16,441,745 41.51

Suven Life Sciences Result Highlights

Suven Life Sciences Synopsis

NSE-Medical-Diversified

Suven Life Sciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 11.84 Cr. and Equity Capital is Rs. 14.54 Cr. for the Year ended 31/03/2022. Suven Life Sciences Ltd. is a Public Limited Listed company incorporated on 09/03/1989 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110TG1989PLC009713 and registration number is 009713.
Market Cap 1,292
Sales 15
Shares in Float 6.54
No of funds 19
Yield 0.89
Book Value 1.97
U/D Vol ratio 2.1
LTDebt / Equity
Alpha -0.09
Beta 1.07

Suven Life Sciences

Owner NameDec-22Nov-22Sep-22Jun-22
Promoters 69.57%64.98%64.98%
Mutual Funds 0.01%0.01%0.01%
Foreign Portfolio Investors 0.46%0.49%0.48%
Financial Institutions/ Banks
Individual Investors 22.98%27.43%27.37%
Others 6.98%7.09%7.16%

Suven Life Sciences Management

Name Designation
Mr. Venkateswarlu Jasti Chairman & CEO
Mrs. Sudharani Jasti Whole Time Director
Mrs. J A S Padmaja Director
Prof. Seyed E Hasnain Director
Mr. M Gopalakrishna Director
Mr. Santanu Mukherjee Director

Suven Life Sciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Suven Life Sciences MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Suven Life Sciences FAQs

What is Share Price of Suven Life Sciences ?

Suven Life Sciences share price is ₹59 As on 08 February, 2023 | 10:11

What is the Market Cap of Suven Life Sciences ?

The Market Cap of Suven Life Sciences is ₹1295.4 Cr As on 08 February, 2023 | 10:11

What is the P/E ratio of Suven Life Sciences ?

The P/E ratio of Suven Life Sciences is -11.6 As on 08 February, 2023 | 10:11

What is the PB ratio of Suven Life Sciences ?

The PB ratio of Suven Life Sciences is 13.5 As on 08 February, 2023 | 10:11

Q2FY23